To support quality improvement (QI) projects in breast cancer, the Association of Community Cancer Centers (ACCC) has joined with Pfizer Independent Grants for Learning and Change (IGLC) to issue a Request for Proposal (RFP) with the intent of funding QI initiatives that fully integrate BRCA testing into patient care plans in order to help inform the treatment decision-making process. The RFP seeks individual grant requests up to a maximum of $150,000. In total, Pfizer will provide $1.5 million in funding for these quality improvement grants.
This grant program provides the opportunity for oncology programs to conduct quality improvement initiatives that address barriers experienced in their local care settings. The opportunity to submit a proposal in response to the RFP is only available to ACCC-member cancer programs and practices. Grant requests should describe concepts and ideas for design and implementation of systems or programs that will close clinical practice gaps related to BRCA testing in breast cancer patients through establishment of education and support mechanisms for community providers.
Download RFP Grant Submission Portal
The RFP process has two stages. Stage 1 is submission of a three-page letter of intent (LOI). If the LOI is selected, the applicant will be invited to submit a full proposal. Deadline for LOI submission is June 26, 2018.
Deadline for submission of the full grant proposal is September 28, 2018.
Questions? Please contact the BRCA Project Coordinator.
Supported by a grant from Pfizer, Inc.
Randall A. Oyer, MD, explains how ACCC is interpreting the data on genetics presented at ASCO 2018 - via OBR